Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03365102
Other study ID # Liu 002017
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 1, 2017
Est. completion date December 31, 2019

Study information

Verified date January 2022
Source Lifespan
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

As a first step toward investigating whether modulation of impulsivity and associated neural pathways may yield clinically meaningful changes in risk for adolescent suicidal behavior, the R21 is a proof-of concept study evaluating the potential for tDCS targeting brain regions associated with behavioral impulsivity (right inferior frontal gyrus [rIFG]) and cognitive impulsivity (left orbitofrontal cortex [lOFC]) to modulate these facets of impulsivity in a sample of adolescent suicide attempters. Participants will be randomly assigned to receive anodal tDCS over the rIFG, anodal tDCS over the lOFC, or a sham stimulation condition, in a three-group design. Task-based measures of behavioral and cognitive impulsivity will be administered before and after tDCS or sham stimulation. Additionally, electroencephalography (EEG) and event-related potential (ERP) data will be collected during the impulsivity tasks, and resting-state EEG data will be collected pre- and post-tDCS administration to confirm engagement of the targeted brain regions and to delineating the neural pathways underlying the effects of tDCS on impulsivity.


Description:

Suicide is one of the leading causes of death in adolescence. To improve the ability to predict and prevent suicidal behavior, there is a pressing need for research in this area to advance beyond identifying risk factors toward a greater focus on the mechanisms of risk for this behavior. In particular, elucidating the neural pathways underlying risk for suicidal behavior is important insofar as such work may yield specific and modifiable targets for clinical intervention. The adoption of new experimental paradigms providing experimental control over potentially modifiable risk factors has been recommended as a means of meaningfully advancing the field in this regard. Although yet to be applied to the study of suicidality, transcranial direct current stimulation (tDCS), in conjunction with measures of electroencephalography (EEG) and event-related potentials (ERPs), may hold promise as an experimental paradigm in the study of potentially modifiable risk factors, and underlying neural mechanisms, for suicidality. One such risk factor of particular relevance to suicide in adolescence is state-sensitive aspects of impulsivity. Impulsivity has been consistently linked with suicidality, with this association appearing to be stronger in adolescence than adulthood. As a first step toward investigating whether modulation of impulsivity and associated neural pathways may yield clinically meaningful changes in risk for adolescent suicidal behavior, the R21 is a proof-of concept study evaluating the potential for tDCS targeting brain regions associated with behavioral impulsivity (right inferior frontal gyrus [rIFG]) and cognitive impulsivity (left orbitofrontal cortex [lOFC]) to modulate these facets of impulsivity in a sample of adolescent suicide attempters. Participants will be randomly assigned to receive anodal tDCS over the rIFG, anodal tDCS over the lOFC, or a sham stimulation condition, in a three-group design. Task-based measures of behavioral and cognitive impulsivity will be administered before and after tDCS or sham stimulation. Additionally, EEG and ERP data will be collected during the impulsivity tasks, and resting-state EEG data will be collected pre- and post-tDCS administration to confirm engagement of the targeted brain regions and to delineating the neural pathways underlying the effects of tDCS on impulsivity.


Recruitment information / eligibility

Status Completed
Enrollment 64
Est. completion date December 31, 2019
Est. primary completion date December 31, 2019
Accepts healthy volunteers No
Gender All
Age group 13 Years to 17 Years
Eligibility Inclusion Criteria: - have attempted suicide prior to admission - speak and read English fluently - do not display evidence of significant cognitive impairment, based on a standard psychiatric exam as well as school records on admission - are not actively psychotic at time of intake. Exclusion Criteria: - a significant general medical condition - history of seizure, head injury, brain surgery or tumor - intracranial metallic implants or implanted electrical devices - substance abuse or dependence in the past six months.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
anodal tDCS over the rIFG,
tDCS at a constant current of 1.5 milliampere (mA) will be applied for one 20-minute session over the right inferior frontal gyrus . Resting-state EEG for 10 minutes will be recorded immediately prior to and after tDCS. After post-tDCS resting state EEG is acquired, EEG is recorded to extract Evoked Response Potentials in a single-blind procedure. The participants and assessors will be blind to experimental condition.
anodal tDCS over the lOFC,
tDCS at a constant current of 1.5 mA will be applied for one 20-minute session over the left orbitofrontal cortex . Resting-state EEG for 10 minutes will be recorded immediately prior to and after tDCS. After post-tDCS resting state EEG is acquired, EEG is recorded to extract Evoked Response Potentials in a single-blind procedure. The participants and assessors will be blind to experimental condition.
sham tDCS stimulation condition
In the sham condition, the current will be ramped up to 1.5 mA for 30 seconds and then ramped back down to 0. As this commonly used sham procedure produces a brief tingling sensation, participants are kept unaware of their experimental condition. Resting-state EEG for 10 minutes will be recorded immediately prior to and after the sham tDCS. After post-sham stimulation resting state EEG is acquired, EEG is recorded to extract Evoked Response Potentials in a single-blind procedure. The participants and assessors will be blind to experimental condition.

Locations

Country Name City State
United States Bradley Hospital Riverside Rhode Island

Sponsors (1)

Lead Sponsor Collaborator
Lifespan

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stop Signal Task (SST) The Stop-Signal Task (SST) is a task requiring inhibition of a prepotent motor response. The SST requires participants to respond to a target stimulus as quickly and accurately as possible by pressing a button, but also to withhold their response when they hear an auditory signal. Thus, this task involves a competition between activating and inhibiting processes. The primary outcome variable is change in the stop signal reaction time (SSRT) for the task administered seconds to minutes before and seconds to minutes after stimulation. The theoretical minimum is zero seconds and there is no theoretical maximum. Higher SSRT scores reflect greater impulsivity. Within an hour post-stimulation condition
Primary Delay Discounting Task This task assessed discounting larger future rewards for smaller immediate ones. The point where a person is equally likely to prefer immediate vs delayed reward (the indifference point) is determined for several and combinations of reward sizes and lengths of time. Area under the curve (AUC) is calculated by summing the results of the following for each delay and indifference point pair: x2-x1[(y1 + y2)/2]. x1 and x2 are successive delays and y1 and y2 are indifference points for those delays. AUC range=0-1. Larger AUCs reflect less impulsivity. Within an hour post-stimulation condition
See also
  Status Clinical Trial Phase
Recruiting NCT03898336 - Eat2beNICE Vitamins and Nutrients as Supplementation for Impulsivity, Irritability, and Compulsivity N/A
Completed NCT03484377 - Cortical Dynamics of Inhibitory Control: A Concurrent tDCS-MEG Study N/A
Terminated NCT03527550 - Cognitive Control Training for Urgency in a Naturalistic Clinical Setting N/A
Recruiting NCT05894980 - How to Reduce Suicidal Thoughts and Impulsivity in Depression N/A
Recruiting NCT03218670 - Your Health in On Click N/A
Not yet recruiting NCT04811807 - Clinical Response of Impulsivity After Brain Stimulation in Parkinson's Disease
Completed NCT02740582 - Effects of Tolcapone on Decision Making and Alcohol Intake in Alcohol Users Phase 2
Not yet recruiting NCT02595164 - Common Decision Making Deficits in Suicidal Behaviors and Eating Disorders N/A
Recruiting NCT04960969 - The Effects of Time-Restricted Eating Model N/A
Not yet recruiting NCT06226467 - Neurobehavioral Affective Control Training N/A
Not yet recruiting NCT03498937 - Effects of tDCS on Impulsiveness Among People Suffering From Borderline Personality Disorder N/A
Completed NCT03200873 - Effects of rTMS on Impulsivity and Empathy N/A
Terminated NCT03838484 - Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia N/A
Completed NCT04290533 - HD-tDCS Over the dACC in High Trait Impulsivity N/A
Completed NCT05031559 - Episodic Future Thinking and Compassion N/A
Completed NCT01158950 - A Study of Neural Circuit Responses to Catechol-O-methyl Transferase (COMT) Inhibitors N/A
Recruiting NCT05875181 - Examining the Impact of Transcranial Focused Ultrasound (tFUS) on Reward Neural Circuitry N/A
Not yet recruiting NCT03190681 - Motivation and Methylphenidate Early Phase 1
Completed NCT01805401 - tDCS Applied to the OFC: Effects on Decision-Making and Impulse Control N/A
Completed NCT03006653 - Understanding Daily Fluctuations in Self-Regulation N/A